1. Home
  2. AUPH vs BKV Comparison

AUPH vs BKV Comparison

Compare AUPH & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$14.88

Market Cap

2.2B

Sector

Health Care

ML Signal

N/A

Logo BKV Corporation

BKV

BKV Corporation

N/A

Current Price

$17.88

Market Cap

2.5B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
AUPH
BKV
Founded
1993
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.5B
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
AUPH
BKV
Price
$14.88
$17.88
Analyst Decision
Buy
Strong Buy
Analyst Count
6
11
Target Price
$18.50
★ $31.36
AVG Volume (30 Days)
819.4K
★ 1.5M
Earning Date
10-30-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 199.00
EPS
0.76
★ 1.37
Revenue
$283,055,000.00
★ $893,781,000.00
Revenue This Year
$16.65
$49.27
Revenue Next Year
$17.73
N/A
P/E Ratio
$19.89
★ $13.64
Revenue Growth
N/A
★ 47.85
52 Week Low
$13.52
$17.53
52 Week High
$19.25
$32.81

Technical Indicators

Market Signals
Indicator
AUPH
BKV
Relative Strength Index (RSI) 32.23 32.08
Support Level $14.76 $17.53
Resistance Level $15.15 $27.40
Average True Range (ATR) 0.53 0.86
MACD -0.19 0.02
Stochastic Oscillator 4.44 13.54

Price Performance

Historical Comparison
AUPH
BKV

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About BKV BKV Corporation

BKV Corp is a growth-driven energy company focused on the development of natural gas-producing assets, the ownership and operation of natural gas-fired power generation assets, and selective accretive acquisitions. The company's core businesses are the production of natural gas and the generation of natural gas-fired power from its owned and operated assets, supported by a closed-loop plan, enabled by its upstream, midstream, power, and CCUS businesses.

Share on Social Networks: